• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

独特型特异性T辅助细胞克隆识别可变重链决定簇。

Idiotype-specific T helper clones recognize a variable H chain determinant.

作者信息

Saeki Y, Chen J J, Shi L F, Okuda Y, Köhler H

机构信息

IDEC Pharmaceuticals Corporation, La Jolla, CA 92037.

出版信息

J Immunol. 1990 Mar 1;144(5):1625-8.

PMID:1689751
Abstract

Previously we described a Th clone specific for a regulatory idiotype on 3A4, an anti-Id mAb that mimics a murine L1210/GZL tumor-associated Ag. In our studies, we determined the molecular target on the stimulating anti-Id antibody that is recognized by the Th clone. The Th clone responds with proliferation to the H chain of 3A4 but not to the L chain. Furthermore, the 3A4 chain stimulates this Th clone more efficiently than either the intact 3A4 or the Fab fragments, and the presentation by APC of the H chain is more resistant to chloroquine treatment than the presentation of the intact 3A4 molecule. These results suggest that regulatory T cells "see" their target idiotopes as linear sequence determinants present on isolated Ig chains, and show that this might have biologic advantages with respect to the mechanism of Ag presentation.

摘要

先前我们描述了一个针对3A4上调节性独特型的Th克隆,3A4是一种模拟鼠L1210/GZL肿瘤相关抗原的抗独特型单克隆抗体。在我们的研究中,我们确定了Th克隆所识别的刺激抗独特型抗体上的分子靶点。该Th克隆对3A4的重链有增殖反应,但对轻链无反应。此外,3A4重链比完整的3A4或Fab片段更有效地刺激该Th克隆,并且抗原呈递细胞对抗原重链的呈递比完整3A4分子的呈递对氯喹处理更具抗性。这些结果表明调节性T细胞将其靶独特型视为存在于分离的Ig链上的线性序列决定簇,并表明这在抗原呈递机制方面可能具有生物学优势。

相似文献

1
Idiotype-specific T helper clones recognize a variable H chain determinant.独特型特异性T辅助细胞克隆识别可变重链决定簇。
J Immunol. 1990 Mar 1;144(5):1625-8.
2
Idiotypic intramolecular help. Induction of tumor-specific antibodies by monoclonal anti-idiotypic antibody with the help of Fc-specific T helper clones.独特型分子内辅助。在Fc特异性T辅助性克隆的帮助下,单克隆抗独特型抗体诱导肿瘤特异性抗体。
J Immunol. 1989 Apr 15;142(8):2629-34.
3
Characterization of "regulatory" idiotope-specific T cell clones to a monoclonal anti-idiotypic antibody mimicking a tumor-associated antigen (TAA).针对模拟肿瘤相关抗原(TAA)的单克隆抗独特型抗体的“调节性”独特型特异性T细胞克隆的鉴定。
J Immunol. 1989 Feb 1;142(3):1046-52.
4
H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.H-2连锁Ir基因对VH决定簇特异性辅助性T细胞的控制。
J Mol Cell Immunol. 1986;2(5):255-64.
5
Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells.肿瘤特异性独特型疫苗。III. 抗独特型和肿瘤细胞对辅助性T细胞的诱导作用。
J Immunol. 1987 Sep 15;139(6):2096-102.
6
Cross-reactive idiotypic determinants on antibodies and antigen-specific helper T cell continuous lines.抗体上的交叉反应独特型决定簇和抗原特异性辅助性T细胞连续系
J Immunol. 1983 Apr;130(4):1814-8.
7
Analysis of the idiotypic network in tumor immunity.肿瘤免疫中独特型网络的分析。
J Immunol. 1987 Dec 1;139(11):3902-10.
8
Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen.肿瘤特异性独特型疫苗。I. 内影像肿瘤抗原的产生与特性
J Immunol. 1986 Sep 1;137(5):1743-9.
9
Allotype-linked production of an idiotype-specific factor that promotes idiotype expression in nonresponder strains.同种异型连锁产生的独特型特异性因子,可促进无反应性品系中的独特型表达。
J Immunol. 1987 Sep 15;139(6):1780-5.
10
Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.识别稳定表位的抗独特型抗体限制了小鼠B细胞淋巴瘤中独特型变体的出现。
J Immunol. 1990 Mar 15;144(6):2436-45.

引用本文的文献

1
Idiotope-Driven T-Cell/B-Cell Collaboration-Based T-Cell Epitope Prediction Using B-Cell Receptor Repertoire Sequences in Infectious Diseases.基于 B 细胞受体库序列的传染病中 idiotope 驱动的 T 细胞/B 细胞协同作用的 T 细胞表位预测。
Viruses. 2023 May 17;15(5):1186. doi: 10.3390/v15051186.
2
Patients receiving murine monoclonal antibody therapy for malignancy develop T cells that proliferate in vitro in response to these antibodies as antigens.接受鼠单克隆抗体治疗恶性肿瘤的患者会产生T细胞,这些T细胞在体外作为抗原对这些抗体产生增殖反应。
Br J Cancer. 1991 Sep;64(3):494-500. doi: 10.1038/bjc.1991.337.